Rhizoma Paridis saponins (RPS) as active parts of P. polyphylla Smith var. yunnanensis has been used as an anti-cancer drug in traditional Chinese medicine. In this study, RPS was first found to demonstrate a potent effect on markedly reducing the pain induced by cancer. Therefore, the aim of this study was to further explore the analgesic effect of RPS and its possible reaction pathway on H22 hepatocarcinoma cells inoculated in the hind right paw of mice. Cancer-induced pain model mice were randomly divided into 5 groups (n ¼ 10) and orally administered with RPS (50-200 mg kg À1 ) for 2 weeks. On the last day of treatment, the pain behavior of mice was measured using hot-plate test and open field test, and brain tissues were sampled for detection of biochemical indices, malondialdehyde (MDA), superoxide dismutase (SOD), prostaglandin E2 (PGE2), serotonin (5-HT) and b-endorphin (b-EP). Moreover, the concentrations of NF-kB and IL-1b in the blood serum were measured by ELISA reagent kits. In addition, naloxone, the non-selective antagonist of opioid receptors, was used to identify the opioid receptors involved in RPS's action. It has been found that RPS alleviates cancer pain mainly via the suppression of inflammatory pain induced by oxidative damage, such as decreasing MDA and PGE2 levels, renewing activity of SOD, as well as increasing 5-HT and b-EP in the brain and suppressing the expression of NFkB and IL-1b in the serum in a concentration-dependent manner. Overall, the current study highlights that RPS has widespread potential antinociceptive effects on a mouse model of chronic cancer pain, which may be associated with the peripheral nervous system and the central nervous system.
Introduction
Pain is the rst symptom of cancer in 30-50% of patients, and it is estimated that at least 70-90% of cancer sufferers will eventually experience chronic pain during their illness.
1 Malignant, long-lasting pain is a frequent symptom in cancer patients that impedes antineoplastic therapy and critically diminishes the health condition of patients.
2 Thus, effective therapy involving various pharmacological and non-pharmacological interferences for treating pain has been extensively explored in both basic research and clinical trials.
According to WHO guidelines, opioids are the mainstay analgesics for moderate to severe pain management. The analgesic effect of opiate drugs occurs through the stimulation of opioid receptors in the central nervous system and the peripheral nervous system. In addition to producing analgesia by exerting their analgesic action in the central nervous system, classical opioids simultaneously cause the onset of undesirable side effects, such as tolerance, nausea or sedation, which are recognized as signicant burdens for cancer patients.
3 Moreover, many patients suffer the pain via the peripheral nervous system induced by inammation during the period of tumor growth.
Reactive oxygen species scavengers (ROS) are natural byproducts of cellular metabolism with important physiological and pathophysiological functions. 4 However, excessive ROS levels due to increased ROS production and/or decreased antioxidant defense ability leads to lipid peroxidation, protein oxidation, and nucleic acid oxidation. 5 When generated beyond the normal physiological range, excessive ROS can cause oxidative stress. Recently, increasing evidence had supported the involvement of ROS in pathological pain induced by cancer. Mechanical allodynia in rats was effectively attenuated by the intrathecal injection of a ROS scavenger, indicating that excessive ROS levels may be closely related to cancer pain development, probably through the peripheral nervous system. mechanisms. 7, 8 The serotonergic system modulates nociception mainly via descending serotonergic pathways that run principally from rostroventromedial medulla through the dorsolateral funiculus. 9, 10 It is known that several different subtypes of spinal 5-HT receptors have been proposed to mediate the antinociceptive effects of 5-HT. b-Endorphin is normally expressed in neurons and it is reported that they specically activate mopioid receptors localized in post-synaptic neurons and modulate pain transmission and transduction.
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To date, opioid analgesics remain the most efficacious pharmacological agents for the treatment of moderate to severe pain, but their therapeutic benet is oen hampered by the development of analgesic tolerance and hyperalgesia.
12 Non-steroidal anti-inammatory drugs (NSAID) are also used to manage pain, but they also have side effects, such as cardiovascular risks and gastrointestinal diseases. 13, 14 Medicinal plants are among the potential adjuvant agents that could also be evaluated in this therapeutic approach. In fact, phytotherapy offers valid support to conventional medicine in a number of diseases, and this also applies to the management of pain. Paris polyphylla is the dried rhizome of P. polyphylla Smith var. yunnanensis, which has been widely used for the treatment of hemostasis, abscess, snake bites, abnormal uterine bleeding, tumors, analgesia and fractures in clinical practice for thousands of years in China. 15, 16 Rhizoma Paridis saponins (RPS) as active parts of P. polyphylla Smith var. yunnanensis has been used as an anti-cancer drug in traditional Chinese medicine. [17] [18] [19] Furthermore, previous studies showed that Rhizoma Paridis saponins display anti-inammatory, antioxidant and antinociceptive effects in rodents. 20, 21 However, the underlying mechanisms by which Rhizoma Paridis saponins reduce the pain induced by cancer are not well understood yet.
A plethora of animal models showing local signs of cancerinduced hypersensitivity have been developed, which accurately mimic cancer pain and produced by the H22 hepatocarcinoma cells implantation into the hind paw. 22, 23 Chronic cancer pain model was established to evaluate the analgesic effect of the oral administration of RPS. We studied the analgesic effect on the pain threshold using the hot-plate test, and we also evaluated the behavioural characteristics of mice by utilizing the open eld test in the cancer pain model. Finally, in order to dene whether the analgesic effect of RPS on cancer pain is related to the central nervous system or/and peripheral nervous system, we evaluated the inuence of RPS on the biochemical changes (SOD, MDA, PGE2, b-EP and 5-HT) induced by cancer pain in brain tissue. These studies point to the analgesic effect of RPS and the relevance of central and peripheral analgesia in cancer pain treatment.
Materials and methods

Materials
Dried rhizomes of P. polyphylla Smith var. yunnanensis were purchased from Yunnan Province, China, and identied by Prof. Wenyuan Gao (Tianjin University, China). Rhizoma Paridis saponins (RPS) were prepared in Tasly Holding Group Co., Ltd. (Tianjin, China) and the method was similar to that previously reported. 24 RPS was suspended in distilled water. 
Cancer pain model establishment
The general method of preparation and implantation of melanoma cells has been published previously. 25 Briey, H22 hepatoma cells, which were collected from the ascites of tumorbearing mice, were suspended in 0.9% sodium chloride. To establish the hind paw cancer pain model, 20 mL H22 hepatoma cells (6 Â 10 7 cells per mL) were subcutaneously implanted into the plantar region of the right hind paw using a 30-gauge needle. Control mice received an equivalent volume of normal saline (NS) injections in right hind paws.
Determination of paw volume
Tumor growth was determined as previously described. 26 Paw thickness and width were measured with an electronic caliper with 0.1 mm accuracy. Paw volume was calculated in the tumorbearing and intact paws according to the following formula: V ¼ (t Â w 2 ) Â 0.52, where V is the paw volume, t is the paw thickness and w is the paw width.
Experimental design
Experiments were conducted on post-inoculation day 14 when mice exhibited a stable decrease in paw licking latency. Analgesic effect was assessed using the hot-plate test. In total, 60 qualied mice were randomly divided into 6 groups of 10 
Effects on open eld test
An open eld (36 cm Â 36 cm) was constructed by enclosing an area of tiled oor with 40 cm-high plywood planks, whose oor was divided into 9 equal squares by black lines. The animals were carefully placed at the center of the open eld and behaviors in 5 min were recorded. Their movement trajectories were recorded by a video camera and analyzed using a tracking soware (TM-Vision, Stoelting, Wood Dale, IL). Immediately thereaer, the animals were anaesthetised with ethyl ether and decapitated. The brains were removed and stored at À80 C until required for assay.
Determination of brain tissue biomarkers
Aer evaluating by the open eld test, the mice were used for the analyses of brain tissue biochemical parameters. In brief, mice were sacriced, and brain tissues were rapidly excised, weighed (0.5 g of each tissue), and homogenized with 2.0 mL of iced normal saline. The interstitial uid was prepared by centrifugation at 1000g at 4 C for 15 min. The supernatant was tested to determine the levels of SOD activities, MDA, PGE2, b-EP and 5-HT. The biomarkers were tested following the recommended procedures provided in the kits. Compared with the model group using one-way ANOVA with Student's t-test, *P < 0.05, **P < 0.01, ***P < 0.01. a Each value represents the mean AE SE. Compared with the model group, *P < 0.05, **P < 0.01, ***P < 0.01.
Measurement of blood NF-kB and IL-1b levels by ELISA assay
Fresh blood samples were collected from the tail veins of cancer pain model mice. Blood serum was separated by centrifugation at 3000 rpm for 20 min. The concentrations of NF-kB and IL-1b in the blood serum were measured by ELISA reagent kits (BD Bioscience, Franklin Lakes, NJ, USA), as detailed by the manufacturer.
Histology
For examination of the primary hind paw tumor and potential metastasis into lungs, all mice were euthanatized with 100 mg kg À1 intraperitoneal pentobarbital sodium (Nembutal, Polfa, Poland). Paws were removed and post xed in Bouin's and 1% paraformaldehyde in 0.1 M PBS solution, respectively. Fixed tissues were embedded in paraffin. Sections (5 mm) were mounted onto Superfrost Plus microscope slides (Fisher Scientic, Pittsburgh, PA) and stained with hematoxylin and eosin. Histopathologic examination was performed under a light microscope (Nikon, Tokyo, Japan).
Involvement of opioid receptors in RPS antinociceptive effect
The involvement of the opioid system in the antinociceptive effect of RPS was studied as previously described. 27 The mice subjected to intraplantar injection of 20 mL formalin (2.5%, i.pl.) were pretreated with either a systemic (i.p.) injection of saline (10 mL 
Statistical analysis
Statistical analyses were conducted using SPSS 17.0 soware. The results are expressed as the mean AE standard error (SE) in tables and are indicated by the vertical bars in gures. Differences between the groups were determined by one-way analysis of variance (ANOVA) and Student's t-test. Correlations were expressed using the Pearson's product-moment correlation coefficient. A probability value (P) less than 0.05 was considered signicant.
Results
Tumor growth
The time-course of tumor growth in mice inoculated with H22 hepatoma cells is shown in Fig. 1 . The paw volume signicantly differed in the tumor-bearing paw, compared to the NS-injected paw (P < 0.001). On day 9 post implantation, there was a signi-cant increase in the volume of the paw inoculated with H22 cells (model: 112.38 AE 13.94 vs. control: 26.55 AE 2.18; P < 0.001, Fig. 1 ). The paw volume of the model group inoculated with H22 cells further increased signicantly until day 14 when animals were sacriced. Moreover, the present results showed that the paw volume was signicantly lower in the RPS-treated group than that in the model group (P < 0.05 and P < 0.01). Mice from the model group developed large-sized tumors (Fig. 2 ) much earlier than the control mice. Furthermore, as shown in Table 1 , RPS with different doses exhibited signicant inhibition effects on tumor weights of paws inoculated with H22 cells, which were 0.36 AE 0.13 g, 0.32 AE 0.15 g and 0.21 AE 0.07 g (P < 0.05 and P < 0.01). Groups of RPS-L, RPS-M, and RPS-H demonstrated increased ratios of inhibition rates, which were 49.33%, 53.86% and 69.47%, respectively. These results indicated that RPS had signicant inhibition effect (P < 0.05) on the growth of tumors in mice with evident dose-effect relationship.
Analgesic effect of RPS in cancer pain model
As shown in Fig. 3 , there was a dose-dependent increase in the analgesic effect in the tumor-bearing paw (P < 0.001 and P < 0.01, Fig. 3 Fig. 4A and B) . The static time of the model group increased and the movement distance reduced during the second to h minutes of observation relative to the control group. A reduction in static time was also observed when the animals were treated with three doses of RPS (50-200 mg kg À1 , i.g.). With these doses, movement distances increased in the third to h minutes in comparison to the model group (Fig. 4B) . Among rats treated with the higher dose of RPS, although the movement distances initially reduced, the values subsequently remained elevated. In addition, movement distances of the positive group also remained elevated in the third to h minutes relative to the model group (Fig. 4B ), but the effect was weaker than that of the group treated with 200 mg kg À1 RPS. The movement track of mice is exhibited in Fig. 5 .
The animal model was well established for the evaluation of drug efficacy on cancer pain, as evidenced by static time and movement distance during the open eld test. These results indicated that the administration of RPS increased the activity level of cancer pain mice, particularly in the group treated with a dose of 200 mg kg À1 . 
Paw histopathology
We rst performed a morphological and histological study to conrm carcinoma formation. At 14 days aer surgery, the transplanted carcinoma caused swelling and severe necrosis. Hematoxylin and eosin (HE) staining of the carcinoma-bearing paw showed the bone marrow cavity of the paw lled with tumor cells and a destroyed muscle matrix (Fig. 6 ).
Effects on MDA of brain tissue
To explore whether RPS would affect endogenous MDA, we utilized an ELISA Kit to quantitatively analyze the level of MDA in brain tissue. The results showed that MDA expression was signicantly increased in the carcinoma-bearing mice when compared to that in the control group (P < 0.01). As shown in Fig. 7 , the levels of MDA were signicantly reduced by the treatment with RPS-H, RPS-M and RPS-L when compared to the model group (P < 0.01), and exhibited a dose-dependent relationship. A similar pattern was also found in the INN group.
Effects on SOD of brain tissue
We next investigated whether RPS could regulate the activation of SOD. The present results indicated that the model group's SOD content was signicantly reduced when compared to that of the control group (P < 0.01, Fig. 8 ), which indicated that the tumor may have induced the decrease in SOD content. Aer the administration of RPS-H and RPS-M, the activity of SOD was drastically up-regulated (P < 0.01).
Effects on PGE2 of brain tissue
The results presented in Fig. 9 show the effect of RPS on the PGE2 level in cancer pain model. As shown in Fig. 9 , the levels of PGE2 in the model group were signicantly higher than that in the control group. However, the increase in PGE2 level in brain tissue was attenuated by the treatment of RPS (50-500 mg kg À1 , i.g.). The positive control INN was also able to signicantly reduce the concentration of PGE2 (P < 0.001). We also found that the tumor growth induced a distinct decrease in the PGE2 level, which was signicantly reversed by RPS in a dosedependent manner. Previous reports demonstrated that the treatment of esophageal cancer cells with RPS signicantly down-regulated the expression of prostaglandin E2 in a dosedependent manner, which is consistent with the result of the present research. ) and 1 h later, their cerebral homogenates were obtained for b-EP measurement. As exhibited in Fig. 10 , the levels of b-EP signicantly increased in the model group compared to that in control mice. Based on previous data, we inferred that the signicant increase in b-endorphin in the brain was due to the release of b-endorphin aer stress and inammation induced by cancer.
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Administration of RPS (50-200 mg kg À1 ) could signicantly increase b-EP levels in brain tissue by 1.14, 1.31 and 1.48 times (P < 0.01, P < 0.001). In addition, treatment with INN in cancer pain mice also signicantly altered the b-EP release (190.68 AE 13.60 vs. 118.13 AE 6.18, P < 0.01).
Effects on 5-HT of brain tissue
Serotonin (5-HT) in the brain and spinal cord plays a critical role in behavioral responses to environmental stressors and nociceptive mechanisms. To investigate the effect of RPS on the ) dose-dependently increased the level of 5-HT in brain tissue (P < 0.01 and P < 0.05, Fig. 11 ). 
Correlation
Pearson correlation coefficients for the relationship between paw licking latency of the hot-plate test and biochemical parameters (SOD activities, MDA, PGE2, b-EP and 5-HT level) in brain tissue are presented in Fig. 12 . Signicant negative correlations were identied between paw licking latency and MDA level (r ¼ À0.605, P < 0.001, Fig. 12A ) and PGE2 level (r ¼ À0.637, P < 0.001, Fig. 12B ), while signicant positive correlations were observed between paw licking latency and SOD activity (r ¼ 0.706, P < 0.001, Fig. 12C) , 5-HT level (r ¼ 0.685, P < 0.001, Fig. 12D ), and b-EP level (r ¼ 0.565, P < 0.01, Fig. 12E ).
Effects on serum NF-kB and IL-1b
To conrm the inuence of inammation and oxidative stress on the analgesic effect of RPS in cancer pain model, blood NFkB and IL-1b levels were measured by ELISA assay (Fig. 14) . The results demonstrated that compared to control mice, the model group expressed markedly increased levels of NF-kB and IL-1b (P < 0.001), which was consistent with the previous study, RPS on established tumor-bearing paw model almost completely suppressed the expression of NF-kB and IL-1b (P < 0.01 and P < 0.001) in a concentration-dependent manner. In addition, treatment with tramadol HCl (INN, 10 mg kg À1 , i.p.) in cancer pain mice also signicantly down-regulated the release of NF-kB and IL-1b (P < 0.01). Using the established model of cancer pain in the hind paw, we found that RPS (50-200 mg kg À1 ) could down-regulate the expression of NF-kB and IL-1b in a concentration-dependent manner. NF-kB and IL-1b released from activated microglia and consequently sensitized the neurons in the spinal dorsal horn by altering the excitatory or inhibitory synaptic transmission, contributing to pain facilitation. 32 It is thus possible that RPS produced antinociception by the blockade of proinammatory cytokine expression via the inhibition of NF-kB and IL-1b activation.
Involvement of opioid receptors in the systemic antinociceptive action of RPS
In order to identify the opioid receptors involved in RPS's action, naloxone (a non-selective antagonist of opioid receptors) was used. The antinociception induced by morphine (nonselective opioid receptor agonist, used as the positive control) was reversed by the pre-treatment with naloxone (Fig. 15A) . Similarly, as shown in Fig. 15B , administration of naloxone (1 mg kg À1 , i.p.) signicantly antagonized the antinociceptive effects Fig. 13 The mechanism of analgesic effect of RPS on cancer-induced pain model mice.
of RPS in comparison to the control group, aer the intraplantar injection of formalin. The opioid hypothesis was preliminarily investigated by attempting to reverse analgesia aer the administration of naloxone (opioid antagonist). 33 The results showed that the pre-administered naloxone was able to counteract the antinociception of RPS, clearly demonstrating an important involvement of RPS in the endogenous opioid receptors' activation to produce analgesia.
Discussion
Numerous studies have found that long-lasting stress and inammation increases an individual's pain during cancer, which is related to the central nervous system and the peripheral nervous system. 34 Because of its multifaceted character, cancerinduced pain remains inadequately controlled, thus posing a challenge for modern medicine. Among traditional systems of medicine, traditional Chinese medicine (TCM) is the most extraordinary system with unique theories and practice in promoting people's health and alleviating diseases for thousands of years. Our results demonstrated that the administration of Rhizoma Paridis saponins (RPS), the active parts of P. polyphylla Smith var. yunnanensis, exhibited a dose-dependent analgesic effect in cancer pain, as evidenced by the hot-plate test, and prevented the development of tumor in size and in histopathology. In addition, the results of biochemical factors suggested the possible involvement of the peripheral nervous system and central nervous system in the observed analgesic effect. 35, 36 The mechanisms and pathways responsible for the analgesic effect of RPS are depicted in Fig. 13 .
Rhizoma Paridis saponins (RPS), as active parts of P. polyphylla Smith var. yunnanensis, has been used as an anti-cancer drug in traditional Chinese medicine for a long time. [17] [18] [19] In the animal model of skin cancer pain presented in this study, mice developed robust thermal hypersensitivity restricted to the tumor-bearing paw that was correlated with the tumor growth ( Fig. 1 and 3 and Table 1 ). In our research, oral administration of RPS (50-200 mg kg
À1
) could delay the growth of tumor, which reduced the stress induced by the tumor. This observation was consistent with those reported in previous studies where RPS was identied as the main effective component of Rhizoma Paridis with antitumor properties. 37, 38 To evaluate the analgesic effect of RPS, the hot-plate test and the open eld test were performed in the present research. The results indicated that RPS exhibited a dose-dependent analgesic effect aer oral administration, which was had a signicant positive correlation with the tumor inhibition rate of RPS. Furthermore, the activity level of cancer pain mice signicantly increased aer treating with RPS, which was also positively correlated with the tumor inhibition rate. Thus, based on present results, it may be hypothesized that the anti-tumor effect of RPS, which is related to stress, may account for the analgesic effect induced by cancer.
Several hypotheses can be formed to explain RPS's analgesic effect demonstrated in the hot-plate test, which was related to the possible involvement of peripheral nervous system and central nervous system. Inammation and neuropathic pain represent major pain categories and involve increased afferent signaling (peripheral sensitization), increased pain transmission (spinal sensitization), and altered central pain connectivity (integration and modulation).
39 Pharmacological studies have demonstrated that IL-1b induces a dose-related increase in PGE2 concentration, which is mediated by COX-2 enzyme in the peripheral inammation system. 40 Related biological factors in brain tissue that contribute to the pain development during cancer, such as MDA, SOD, PGE2, NF-kB, IL-1b, b-EP and 5-HT, were measured in this research. These biological factors are involved with peripheral nervous system and central nervous system. 6, 40, 41 Superoxide dismutase (SOD), the most studied antioxidant enzyme, is ubiquitous in all organisms. Recently, SOD was shown to be involved in cancer pain states. An acute inam-matory process consists of inammation mediators, including neutrophil-derived reactive oxygen species (ROS), which play an important role in pathogenesis of many diseases, such as local or systemic inammatory disorders, diabetes, atherosclerosis, cancer, and neurodegenerative diseases.
42,43 ROS generation is induced by growth factors, cytokines, and tumor promoters.
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MDA can injure the quadriceps femoris cells, induce lipid peroxidation, attack nucleic acids and proteins, and nally disrupt the biological functions of the cell. 45 The natural cellular antioxidant enzyme SOD is accepted as one of the most important physiological antioxidants that mediates free radicals and prevents subsequent lipid peroxidation by increasing the rate at which they are removed. 46 SOD mimetic compounds and antioxidants have exhibited potent analgesic effects in rodent pain models.
6 Furthermore, extensive research has shown that the ROS-dependent COX pathway may contribute to the production of PGE2. 47 However, among inammatory factors, PGE2 is known to play the most important role in pain related to the peripheral nervous system. 48 PGE2 can reduce the neuronal threshold, speed the ring and depolarization and consequently increase the number of action potentials per stimulus and reproduce the pain. 49 In our study, data obtained from ELISA showed that SOD expression decreased, while MDA and PGE2 expression increased in mouse model of cancer pain. Moreover, the present results indicated that RPS treatment reduced tumor-induced oxidative and inammation damage via the increase in SOD and the reduction in MDA and PGE2 levels. Based on existing evidence, we propose that RPS would have potential analgesic effect on the peripheral nervous system through regulated tumor-induced oxidative and inammation damage.
b-Endorphin (b-EP) is an endogenous opioid peptide neurotransmitter, which is produced from neurons in the pituitary gland and the hypothalamus; it specically activates post-synaptic m-opioid receptors to modulate pain transmission and transduction 50, 51 and induces analgesic tolerance. 52, 53 In this study, compared to the model group, the expression of b-EP signicantly increased in brain tissue aer treatment with RPS (50-200 mg kg À1 ). Therefore, we speculated that b-endorphin expression in brain tissue and subsequent activation of neuronal m-opioid receptors are the mechanisms responsible for RPS's analgesic effect. Our current data provided additional evidence that Rhizoma Paridis saponins might stimulate b-endorphin expression, which is one of the transmitters for microglia to produce analgesia. Serotonin (5-HT) is involved in some central nervous system diseases, such as stress/anxiety and depression; these pathological conditions are related to changes in serotonergic activity. 54 In particular, increased serotonin release was induced by the acute administration of physiological stressors in some brain areas of mice. A previous study showed that 5-HT was involved in analgesia in a neuropathic pain model. 55 Our data further demonstrated that RPS may increase the spinal release of 5-HT that acts on 5-HT receptor to alleviate hyperalgesia. Opioid and serotonin pathways clearly play a key role in the anesis of pain perception through the release of endogenous opioids and 5-HT that act on specic receptors aer the oral administration of RPS.
Paris polyphylla is the dried rhizome of P. polyphylla Smith var. yunnanensis, which has been widely used for the treatment of hemostasis, abscess, snake bites, abnormal uterine bleeding, tumors, analgesia and fractures in clinical practice for thousands of years in China. 15, 16 Surprisingly, in this study, the results indicated that the oral administration of RPS has markedly reduced the pain induced by cancer inoculated in the hind right paw of mice. Interestingly, in addition to antinociceptive mechanisms, RPS appears to modulate the activation of biochemical parameters, such as SOD, MDA, PGE2, b-EP and 5-HT, which are related to the possible involvement of the peripheral nervous system and the central nervous system in the observed analgesic effect.
Conclusion
In summary, our study provides new evidence that in a mouse model of chronic cancer pain, RPS alleviates the symptoms of cancer pain in mice, increases the activity level and raises the À1 , i.g.) significantly reverses the antinociceptive effects of these treatments, when compared to the control group, after intraplantar injection of formalin (2.5%, i.pl.) in mice. Each column represents the mean of 6 mice, and the vertical lines indicate the SE. ***P < 0.001 as compared with control group or ### P < 0.001 when comparing treatment with naloxone + treatment (one-way ANOVA followed by and Student's t-test).
pain threshold according to the hot-plate test and open eld test. The mechanism may involve the down-regulation of MDA, PGE2, NF-kB and IL-1b levels and the up-regulation of the activity of SOD and the expression of 5-HT and b-EP in brain tissue in the hind right paw tumor model. In addition, this peripheral and central analgesic pathway might have widespread potential for clinical use.
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